使用剂量-面积乘积评估机器人放射外科手术的计划质量。

IF 2.4 4区 医学 Q2 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Zeitschrift fur Medizinische Physik Pub Date : 2024-08-01 DOI:10.1016/j.zemedi.2023.01.001
{"title":"使用剂量-面积乘积评估机器人放射外科手术的计划质量。","authors":"","doi":"10.1016/j.zemedi.2023.01.001","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><p>In robotic stereotactic radiosurgery (SRS), optimal selection of collimators from a set of fixed cones must be determined manually by trial and error. A unique and uniformly scaled metric to characterize plan quality could help identify Pareto-efficient treatment plans.</p></div><div><h3>Methods</h3><p>The concept of dose-area product (DAP) was used to define a measure (DAP<sub>ratio</sub>) of the targeting efficiency of a set of beams by relating the integral DAP of the beams to the mean dose achieved in the target volume. In a retrospective study of five clinical cases of brain metastases with representative target volumes (range: 0.5–5.68 ml) and 121 treatment plans with all possible collimator choices, the DAP<sub>ratio</sub> was determined along with other plan metrics (conformity index CI, gradient index R50%, treatment time, total number of monitor units TotalMU, radiotoxicity index f12, and energy efficiency index η50%), and the respective Spearman's rank correlation coefficients were calculated. The ability of DAP<sub>ratio</sub> to determine Pareto efficiency for collimator selection at DAP<sub>ratio</sub> &lt; 1 and DAP<sub>ratio</sub> &lt; 0.9 was tested using scatter plots.</p></div><div><h3>Results</h3><p>The DAP<sub>ratio</sub> for all plans was on average 0.95 ± 0.13 (range: 0.61–1.31). Only the variance of the DAP<sub>ratio</sub> was strongly dependent on the number of collimators. For each target, there was a strong or very strong correlation of DAP<sub>ratio</sub> with all other metrics of plan quality. Only for R50% and η50% was there a moderate correlation with DAP<sub>ratio</sub> for the plans of all targets combined, as R50% and η50% strongly depended on target size. Optimal treatment plans with CI, R50%, f12, and η50% close to 1 were clearly associated with DAP<sub>ratio</sub> &lt; 1, and plans with DAP<sub>ratio</sub> &lt; 0.9 were even superior, but at the cost of longer treatment times and higher total monitor units.</p></div><div><h3>Conclusions</h3><p>The newly defined DAP<sub>ratio</sub> has been demonstrated to be a metric that characterizes the target efficiency of a set of beams in robotic SRS in one single and uniformly scaled number. A DAP<sub>ratio</sub> &lt; 1 indicates Pareto efficiency. The trade-off between plan quality on the one hand and short treatment time or low total monitor units on the other hand is also represented by DAP<sub>ratio</sub>.</p></div>","PeriodicalId":54397,"journal":{"name":"Zeitschrift fur Medizinische Physik","volume":null,"pages":null},"PeriodicalIF":2.4000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0939388923000016/pdfft?md5=11d050dcb968a77bf2766b4dbaca3618&pid=1-s2.0-S0939388923000016-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Use of dose-area product to assess plan quality in robotic radiosurgery\",\"authors\":\"\",\"doi\":\"10.1016/j.zemedi.2023.01.001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Purpose</h3><p>In robotic stereotactic radiosurgery (SRS), optimal selection of collimators from a set of fixed cones must be determined manually by trial and error. A unique and uniformly scaled metric to characterize plan quality could help identify Pareto-efficient treatment plans.</p></div><div><h3>Methods</h3><p>The concept of dose-area product (DAP) was used to define a measure (DAP<sub>ratio</sub>) of the targeting efficiency of a set of beams by relating the integral DAP of the beams to the mean dose achieved in the target volume. In a retrospective study of five clinical cases of brain metastases with representative target volumes (range: 0.5–5.68 ml) and 121 treatment plans with all possible collimator choices, the DAP<sub>ratio</sub> was determined along with other plan metrics (conformity index CI, gradient index R50%, treatment time, total number of monitor units TotalMU, radiotoxicity index f12, and energy efficiency index η50%), and the respective Spearman's rank correlation coefficients were calculated. The ability of DAP<sub>ratio</sub> to determine Pareto efficiency for collimator selection at DAP<sub>ratio</sub> &lt; 1 and DAP<sub>ratio</sub> &lt; 0.9 was tested using scatter plots.</p></div><div><h3>Results</h3><p>The DAP<sub>ratio</sub> for all plans was on average 0.95 ± 0.13 (range: 0.61–1.31). Only the variance of the DAP<sub>ratio</sub> was strongly dependent on the number of collimators. For each target, there was a strong or very strong correlation of DAP<sub>ratio</sub> with all other metrics of plan quality. Only for R50% and η50% was there a moderate correlation with DAP<sub>ratio</sub> for the plans of all targets combined, as R50% and η50% strongly depended on target size. Optimal treatment plans with CI, R50%, f12, and η50% close to 1 were clearly associated with DAP<sub>ratio</sub> &lt; 1, and plans with DAP<sub>ratio</sub> &lt; 0.9 were even superior, but at the cost of longer treatment times and higher total monitor units.</p></div><div><h3>Conclusions</h3><p>The newly defined DAP<sub>ratio</sub> has been demonstrated to be a metric that characterizes the target efficiency of a set of beams in robotic SRS in one single and uniformly scaled number. A DAP<sub>ratio</sub> &lt; 1 indicates Pareto efficiency. The trade-off between plan quality on the one hand and short treatment time or low total monitor units on the other hand is also represented by DAP<sub>ratio</sub>.</p></div>\",\"PeriodicalId\":54397,\"journal\":{\"name\":\"Zeitschrift fur Medizinische Physik\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2024-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S0939388923000016/pdfft?md5=11d050dcb968a77bf2766b4dbaca3618&pid=1-s2.0-S0939388923000016-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Zeitschrift fur Medizinische Physik\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0939388923000016\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Zeitschrift fur Medizinische Physik","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0939388923000016","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0

摘要

目的:在机器人立体定向放射手术(SRS)中,从一组固定锥体中选择最佳准直器必须通过人工试验和误差来确定。一种独特的、统一标度的计划质量指标有助于确定帕累托效率治疗计划:方法:剂量-面积乘积(DAP)的概念被用来定义一组射束的靶向效率的衡量标准(DAPratio),即射束的积分 DAP 与靶体积内达到的平均剂量之间的关系。在一项针对五例具有代表性靶体积(范围:0.5-5.68 毫升)的脑转移临床病例和 121 种治疗方案(包括所有可能的准直器选择)的回顾性研究中,DAPratio 与其他方案指标(符合性指数 CI、梯度指数 R50%、治疗时间、监测单位总数 TotalMU、放射性毒性指数 f12 和能量效率指数 η50%)一起被确定,并计算了各自的斯皮尔曼等级相关系数。DAPratio 在 DAPratio 比率下确定准直器选择帕累托效率的能力 结果:所有计划的 DAPratio 平均为 0.95 ± 0.13(范围:0.61-1.31)。只有 DAPratio 的方差与准直仪数量密切相关。对于每个目标,DAPratio 与计划质量的所有其他指标都有很强或非常强的相关性。由于 R50% 和 η50% 在很大程度上取决于目标大小,因此只有 R50% 和 η50% 与所有目标计划的 DAPratio 存在中等程度的相关性。CI、R50%、f12 和 η50% 接近 1 的最佳治疗方案与 DAPratio 比值明显相关:新定义的 DAPratio 已被证明是一种衡量标准,它能用一个单一的、统一比例的数字来描述机器人 SRS 中一组光束的靶效率。DAPratio 比率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Use of dose-area product to assess plan quality in robotic radiosurgery

Purpose

In robotic stereotactic radiosurgery (SRS), optimal selection of collimators from a set of fixed cones must be determined manually by trial and error. A unique and uniformly scaled metric to characterize plan quality could help identify Pareto-efficient treatment plans.

Methods

The concept of dose-area product (DAP) was used to define a measure (DAPratio) of the targeting efficiency of a set of beams by relating the integral DAP of the beams to the mean dose achieved in the target volume. In a retrospective study of five clinical cases of brain metastases with representative target volumes (range: 0.5–5.68 ml) and 121 treatment plans with all possible collimator choices, the DAPratio was determined along with other plan metrics (conformity index CI, gradient index R50%, treatment time, total number of monitor units TotalMU, radiotoxicity index f12, and energy efficiency index η50%), and the respective Spearman's rank correlation coefficients were calculated. The ability of DAPratio to determine Pareto efficiency for collimator selection at DAPratio < 1 and DAPratio < 0.9 was tested using scatter plots.

Results

The DAPratio for all plans was on average 0.95 ± 0.13 (range: 0.61–1.31). Only the variance of the DAPratio was strongly dependent on the number of collimators. For each target, there was a strong or very strong correlation of DAPratio with all other metrics of plan quality. Only for R50% and η50% was there a moderate correlation with DAPratio for the plans of all targets combined, as R50% and η50% strongly depended on target size. Optimal treatment plans with CI, R50%, f12, and η50% close to 1 were clearly associated with DAPratio < 1, and plans with DAPratio < 0.9 were even superior, but at the cost of longer treatment times and higher total monitor units.

Conclusions

The newly defined DAPratio has been demonstrated to be a metric that characterizes the target efficiency of a set of beams in robotic SRS in one single and uniformly scaled number. A DAPratio < 1 indicates Pareto efficiency. The trade-off between plan quality on the one hand and short treatment time or low total monitor units on the other hand is also represented by DAPratio.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
3.70
自引率
10.00%
发文量
69
审稿时长
65 days
期刊介绍: Zeitschrift fur Medizinische Physik (Journal of Medical Physics) is an official organ of the German and Austrian Society of Medical Physic and the Swiss Society of Radiobiology and Medical Physics.The Journal is a platform for basic research and practical applications of physical procedures in medical diagnostics and therapy. The articles are reviewed following international standards of peer reviewing. Focuses of the articles are: -Biophysical methods in radiation therapy and nuclear medicine -Dosimetry and radiation protection -Radiological diagnostics and quality assurance -Modern imaging techniques, such as computed tomography, magnetic resonance imaging, positron emission tomography -Ultrasonography diagnostics, application of laser and UV rays -Electronic processing of biosignals -Artificial intelligence and machine learning in medical physics In the Journal, the latest scientific insights find their expression in the form of original articles, reviews, technical communications, and information for the clinical practice.
期刊最新文献
Editorial Board Contents Development and clinical implementation of a digital system for risk assessments for radiation therapy End-to-end testing for stereotactic radiotherapy including the development of a Multi-Modality phantom Note on uncertainty in Monte Carlo dose calculations and its relation to microdosimetry
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1